Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-023697-39Phase 2Active
Phase 2, open-label, single-arm trial of ceftriaxone and cefixime in acute pyelonephritis, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Clinical cure and urine culture negativization at day 9. Started Nov 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-023697-39.